Genotypic Technology Private Limited, a active private limited company, was established on 09 October 1998 in Bangalore, Karnataka, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U72200KA1998PTC049038. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.58 M.
It upholds a compliant status. Employing 82 professional, Its leadership includes Raja Chinnadurai Mugasimangalam (Managing Director), Sudha Narayan Rao (Whole-Time Director). Past directors included Anuja Vivek Joshi, Ramesh Kannan. It holds ₹7.50 Cr open charges and ₹1.77 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 259, Apurva, 2Nd Floor, 4Th Cross, 80 Feet Road, R. M. V. 2Nd Stage,, Bangalore, Karnataka, 560094.
U72200KA1998PTC049038
049038
09 October 1998
₹5.00 M
₹2.58 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Genotypic Technology Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raja Chinnadurai Mugasimangalam | Managing Director | 09 Oct 1998 | Current |
| Sudha Narayan Rao | Whole-Time Director | 29 Sep 1999 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 16 Mar 2020 | Past |
| Pramod Abcsdd | Director | 30 Dec 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genotypic Technology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 60.48% increase. The company also saw a substantial improvement in profitability, with a 62.34% increase in profit. The company's net worth Soared by an impressive increase of 44.48%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Genotypic Technology had a promoter holding of 70.52% and a public holding of 29.48%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹75,038,496.00
₹17,660,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2022 | Hdfc Bank Limited | ₹1.41 M | Open |
| 14 Dec 2012 | Canara Bank | ₹1.13 M | Open |
| 19 Jul 2008 | Canara Bank | ₹7.25 Cr | Open |
| 30 May 2014 | Siemens Financial Services Private Limited | ₹1.40 Cr | Satisfied |
| 30 Mar 2009 | Canara Bank | ₹0.29 M | Satisfied |
Explore comprehensive loan charge details -
Genotypic Technology has a workforce of 82 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Genotypic Technology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genotypic Technology's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 30 May 2014 via Charge ID 10512009 with Siemens Financial Services Private Limited was fully satisfied on 22 Apr 2025. was recorded as a recent event.
Progress on Genotypic Technology Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
A charge with Canara Bank of Rs. 72.50 M registered on 19 Jul 2008 with Charge ID 10118223 was modified on 16 Aug 2024. was recorded as a recent event.
Progress on Genotypic Technology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 1.41 M with Charge ID 100577682 was registered on 25 Mar 2022. was documented.
The activity A charge registered on 30 Mar 2009 via Charge ID 10158054 with Canara Bank was fully satisfied on 21 Nov 2016. was completed.
The CIN of Genotypic Technology Private Limited is U72200KA1998PTC049038.
Genotypic Technology Private Limited is headquartered at No. 259, Apurva, 2Nd Floor, 4Th Cross, 80 Feet Road, R. M. V. 2Nd Stage,, Bangalore, Karnataka, 560094.
Genotypic Technology Private Limited was incorporated on 09 October 1998.
The current directors of Genotypic Technology Private Limited are
The primary industry of Genotypic Technology Private Limited is Professional, Scientific And Technical.
Genotypic Technology Private Limited is unlisted.
The authorized capital of Genotypic Technology Private Limited is ₹5.00 M, and the paid-up capital is ₹2.58 M.
The compliance status of Genotypic Technology Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX